US Patent Issued to HIFIBIO on June 9 for "Anti-galectin-9 antibody and uses thereof" (French, American Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,794, issued on June 9, was assigned to HIFIBIO INC. (Cambridge, Mass.).

"Anti-galectin-9 antibody and uses thereof" was invented by Germain Margall Ducos (Saint Maurice, France), Rachel Pacherie (Sceaux, France), Nicola Arturo Aldo Beltraminelli (Villeurbanne, France), Francisco Adrian (Belmont, Mass.), Liang Schweizer (Cambridge, Mass.), Muriel David (Cambridge, Mass.) and Yun-Yueh Lu (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides humanized monoclonal antibodies against Gal9, and method of using the antibodies to treat cancer, including combination therapy with antagonists of the PD-1/PD-L1 immune checkpoint....